Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.18 USD | -1.55% |
|
-1.40% | +87.06% |
06-24 | Heron Therapeutics, Inc.(NasdaqCM:HRTX) added to S&P Biotechnology Select Industry Index | CI |
06-12 | Connect Biopharma Names New Chief Executive, Chair | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+87.06% | 479M | |
+37.76% | 52.5B | |
-7.47% | 39.01B | |
+37.72% | 39.31B | |
+11.93% | 26.2B | |
-11.17% | 26.57B | |
+16.45% | 28.2B | |
+45.05% | 14.15B | |
+33.13% | 12.62B | |
-3.46% | 11.74B |
- Stock Market
- Equities
- HRTX Stock
- News Heron Therapeutics, Inc.
- Heron Therapeutics Submits Prior Approval Supplement to the FDA for Zynrelef Vial Access Needle